Fluorouracil 5% Cream
Indication
Topical treatment of superficial pre-malignant skin lesions.
Green
Brand:
Efudix
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Skin
Background
Prescribers should refer patients with skin lesions suggestive of skin cancers using the principles of the NICE suspected cancer guideline. Patients must be counselled in full on the correct use of fluorouracil 5% Cream, its risks and side effects.
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: